PLRZ
Polyrizon Ltd. Ordinary Shares
NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY
$14.00
-0.99% today
Updated 2026-05-06
Market cap
$26.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.90
Dividend yield
—
52W range
$3 – $665
Volume
0.0M
Polyrizon Ltd. Ordinary Shares (PLRZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-73000.00 | $-492000.00 | $-1.13M | $-537000.00 | $-1.15M | $-4.53M |
| Capital expenditures | $6000.00 | $18999.00 | $3000.00 | $0.00 | $0.00 | $7000.00 |
| Depreciation | $1000.00 | $6000.00 | $5000.00 | $4000.00 | $118000.00 | — |
| Stock-based comp | — | $184000.00 | $130000.00 | $100000.00 | $51000.00 | $1.31M |
| Free cash flow | $-79000.00 | $-510999.00 | $-1.14M | $-537000.00 | $-1.15M | $-4.54M |
| Investing cash flow | $-6000.00 | $-19000.00 | $-3000.00 | — | $29000.00 | — |
| Financing cash flow | $89000.00 | $1.02M | $648000.00 | $505000.00 | $3.67M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |